Core Viewpoint - Baiyang Pharmaceutical (301015) has signed a strategic cooperation agreement with Tianjin Jikun Pharmaceutical Technology and its actual controller, aiming to leverage both parties' resource advantages. The specific cooperation details will be further negotiated, and the agreement is not expected to significantly impact the company's current year operating performance. However, deeper collaboration in the future is anticipated to enhance the company's sustainable profitability and positively affect its performance [1]. Summary by Relevant Sections - Strategic Cooperation Agreement: The agreement includes cooperation plans and rights arrangements for the parties involved, with specific details to be determined through further negotiations [1]. - Impact on Financial Performance: The signing of the agreement is not expected to have a major impact on the company's operating results for the current year, but it is projected to benefit the company's performance positively as the collaboration deepens [1].
百洋医药：与天津济坤医药科技签署战略合作协议